LNTHLantheus Holdings, Inc.

$5B

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$86M+0.2% YoY

Gross Profit

$45M52.0% margin

Operating Income

$15M17.0% margin

Net Income

$6M7.5% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

-0.9%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$390M

Total Liabilities

$298M

Stockholders' Equity

$92M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$86M	+0.2%
Gross Profit	$45M	$44M	+1.7%
Operating Income	$15M	$16M	-8.7%
Net Income	$6M	$10M	-34.2%

Revenue Segments

US Segment

$150M88%

International Segment

$21M12%

LNTH Q2 2019 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena